Federal contract award
75F40123C00191
THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF A RABBIT MODEL TO CHARACTERISE ANTIFUNGAL DRUG RESISTANCE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $633.7K |
| Current contract value | $633.7K |
| Potential contract value / ceiling | $633.7K |
| Start date | Sep 22, 2023 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Sep 24, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 24, 2025 | P00002 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2026. |
| Jun 27, 2025 | P00001 | $0 | THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF A RABBIT MODEL TO CHARACTERISE ANTIFUNGAL DRUG RESISTANCE. |
| Sep 22, 2023 | 0 | $633.7K | THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF A RABBIT MODEL TO CHARACTERISE ANTIFUNGAL DRUG RESISTANCE. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | May 18, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | May 18, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 17, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 17, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 9, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 9, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 9, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 9, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 4, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 4, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 4, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 4, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 3, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 3, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Nov 17, 2022 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Nov 17, 2022 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Nov 14, 2022 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Nov 14, 2022 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.